跳至主要内容
临床试验/CTRI/2020/12/029883
CTRI/2020/12/029883招募中4 期

Evaluation of efficacy and tolerability of Abhraloha tablets in iron deficiency anaemia â?? Phase IV study - AIDA

Shree Dhootapapeshwar Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Patients ready to give informed consent.
  • Patients of either gender between 18 to 50 years
  • Patients fulfilling diagnostic criteria

排除标准

  • Anemia other than Iron deficiency.
  • K/C/O Thalassemia, Myelodysplastic syndrome, Co-exsisting infection, Inflammation etc
  • K/C/O serious Hepatic, Renal, Pulmonary disease, malignancy etc.
  • Patients receiving treatment with any other hematinic drug or multivitamins will be excluded from study.
  • Pregnant and Lactating Woman
  • Past history of hypersensitivity to any of the ingredients of study medicine.

研究者

相似试验